ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 24 filers reported holding ARMATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300,000 | +163.2% | 100,000 | 0.0% | 0.00% | – |
| Q2 2023 | $114,000 | -31.7% | 100,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $167,000 | +34.7% | 100,000 | 0.0% | 0.00% | – |
| Q4 2022 | $124,000 | -70.6% | 100,000 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $422,000 | +8.5% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $389,000 | -20.4% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $489,000 | -10.8% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $548,000 | +202.8% | 100,000 | +100.0% | 0.00% | – |
| Q3 2021 | $181,000 | -8.6% | 50,000 | 0.0% | 0.00% | – |
| Q2 2021 | $198,000 | -17.2% | 50,000 | 0.0% | 0.00% | – |
| Q1 2021 | $239,000 | +100.8% | 50,000 | +25.0% | 0.00% | – |
| Q4 2020 | $119,000 | -7.0% | 40,000 | 0.0% | 0.00% | – |
| Q3 2020 | $128,000 | -18.5% | 40,000 | 0.0% | 0.00% | – |
| Q2 2020 | $157,000 | +26.6% | 40,000 | 0.0% | 0.00% | – |
| Q1 2020 | $124,000 | +90.8% | 40,000 | +100.0% | 0.00% | – |
| Q4 2019 | $65,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 113,682 | $623,000 | 0.01% |
| SeaCrest Wealth Management, LLC | 13,500 | $74,000 | 0.01% |
| SYNOVUS FINANCIAL CORP | 48,035 | $263,000 | 0.00% |
| Renaissance Technologies | 84,796 | $465,000 | 0.00% |
| Edgewood Management | 100,000 | $548,000 | 0.00% |
| ROYAL BANK OF CANADA | 43 | $0 | 0.00% |
| VANGUARD GROUP INC | 262,750 | $1,440,000 | 0.00% |
| UBS Group AG | 2,036 | $11,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $3,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 624 | $3,000 | 0.00% |